Human immune healthStudy complete
T‑Booster
18-ingredient formulation for immune health.Four years of R&D shaped the programme.Two controlled studies involved 260 adults.
View commercial opportunity →Founder profile · Dr Md Arif Sheikh
From scientistto entrepreneur.
After years in academic research, Dr Sheikh chose to move beyond studying scientific problems and start building solutions around them. In 2018, he founded AVIX Pharmaceuticals Limited in the UK — the beginning of an entrepreneurial journey that now spans three science-led ventures.
THE ENTREPRENEURIAL JOURNEY
01
FoundationAcademic science
02
DecisionTranslate, not only study
03
2018 · United KingdomAVIX Pharmaceuticals Limited
T‑BoosterHuman immune health
Green AntibioticsAnimal health & AMR
AVIX WaterMineral hydration
2018AVIX FOUNDED IN THE UK
3 venturesONE FOUNDER JOURNEY
20+ yearsSCIENTIFIC EXPERIENCE
260 adultsT‑BOOSTER CLINICAL PROGRAMME
01 · The turning point
Leaving academiato translate science.
Academic research gave Dr Sheikh the discipline to ask difficult questions, interrogate evidence and understand biological systems. But over time, he became increasingly interested in what happened after discovery: could scientific thinking be turned into products that were specified, testable and useful in the real world?
That question changed the direction of his career. He chose to leave academia and, in 2018, founded AVIX Pharmaceuticals Limited in the United Kingdom as a startup company built around science translation.
The ambition was broader than creating one product. It was to build the capability to identify a worthwhile problem, develop a reasoned solution, generate evidence around it and create a credible route towards market.
“The shift was from studying science to building with it.”
02 · Building AVIX
Three ventures emergedfrom one founder thesis.
The markets are different. The entrepreneurial logic is the same: start with a defined problem, use science to shape the product, measure what matters and build only as far as the evidence justifies.
Animal health & AMRPre-seed
Green Antibiotics
Plant-derived antimicrobial combinations.Forty-one combinations were screened.Seven progressed into in-vitro work.
Visit Green Antibiotics ↗Mineral hydrationFormulation
AVIX Water
Mineral and functional-water platform.Built around defined composition and testing.Disciplined development for hydration.
Visit AVIX Water ↗Different categories, different evidence stages and different regulatory pathways — connected by one founder's approach to translating science into products.
Explore AVIX Pharmaceuticals ↗03 · Founder method
Science sets the direction.Execution builds the venture.
The entrepreneurial value is not simply having three ideas. It is building a repeatable way to move an idea from scientific rationale towards something that can be evaluated, manufactured, partnered and commercialised.
Choose the problem
Define the need before the product.Do not start with a product-led story.Build only where the problem is clear.
Specify the solution
Turn rationale into a defined solution.Set formulation or screening precisely.Make the proposition testable.
Generate evidence
Choose the right comparator.Measure what matters most.Keep uncertainty and limits visible.
Create the pathway
Align manufacturing, IP and partners.Prepare distribution and market routes.Advance only as evidence supports.
04 · T‑Booster as proof of execution
T‑Booster has travelledfurthest towards market.
Within the founder portfolio, T‑Booster is the clearest demonstration of translation to date: a scientific hypothesis developed into a defined formulation, a manufacturing route, a controlled human research programme and a current commercial pathway.
For an investor or strategic partner, the important signal is continuity — the founder has remained involved from scientific rationale through team building, study execution and launch preparation.